The future of the global wearable medical device market looks promising with opportunities in home healthcare and remote patient monitoring. The global wearable medical device market is expected to reach an estimated $9.4 billion by 2022 and it is forecast to grow at a CAGR of 14.9% from 2017 to 2022. The major drivers of growth are increasing awareness and importance of fitness and healthy lifestyle, rising chronic diseases, and technological innovations.
Emerging trends, which have a direct impact on the dynamics of the global wearable medical device market, include the increasing usage of wearable biofeedback devices and increasing adoption of cloud technology for interconnected healthcare devices. Medtronic Plc, Roche Holding AG, and Animas Corporation (Johnson & Johnson) are the major manufacturers of the wearable medical device market.
A total of 110 figures / charts and 71 tables are provided in this 163-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of global wearable medical device market report, download the report brochure.
The study includes a forecast for the growth opportunities in the global wearable medical device market by end use type, application, distribution channel and region, as follows:
Wearable medical device market by application [Value ($ million) from 2011 to 2022]:
-
Diagnostic
-
Vital Sign Monitoring
-
Neuromodulation
-
Fetal and Obstetric
-
Therapeutic
-
Pain Management Wearables
-
Diabetic
-
Rehabilitation
-
Respiratory
Wearable medical device market by end use market [Value $ million from 2011 to 2022]:
-
Healthcare
-
Remote Patient Monitoring
-
Wearable medical device market by distribution channel [Value $ million from 2011 to 2022]:
-
Pharmacy and Clinics
-
Others and Online
Wearable medical device market by region [Value ($ million) and Volume (million units) from 2011 to 2022]:
-
North America
-
US
-
Canada
-
Mexico
-
Europe
-
United Kingdom
-
Germany
-
France
-
Spain
-
Italy
-
Asia Pacific
-
China
-
Japan
-
Australia
-
S. Korea
-
The Rest of the World
-
Latin America
-
Middle East
Wearable medical device companies profiled in this market report include Medtronic Plc, Roche Holding AG, and Animas Corporation (Johnson & Johnson).
In this market, diagnostic wearable and therapeutic wearable are the main segments by application type. On the basis of its comprehensive research, Lucintel forecasts that diagnostic wearable device is expected to show highest growth during the forecast period from 2017 to 2022.
North America is expected to remain the largest as well as the highest growth region due to high disposable income, rising chronic conditions and acceptance of technologically advanced products in this region.
Some of the features of “Growth Opportunities in the wearable medical device Market 2017-2022: Market Size, Market Share, and Forecast Analysis” include:
-
Market size estimates: wearable medical device market size estimation in terms of volume (M Units) and value ($M) shipment.
-
Trend and forecast analysis: wearable medical device market trend (2011-2016) and forecast (2017-2022) by regions, products and applications.
-
Segmentation analysis: wearable medical device market size by end use type, application, distribution channel in terms of value.
-
Regional analysis: wearable medical device market breakdown by region such as, North America, Europe, Asia Pacific and Rest of the World
-
Growth opportunities: Analysis on growth opportunities in different end use type, application, distribution, and region of wearable medical device market.
-
Strategic analysis: This includes M&A, new product development, competitive landscape, and expansion strategies of wearable medical device suppliers.
-
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q. 1. What are some of the most promising, high-growth opportunities for the global wearable medical device market by end use (healthcare, remote patient monitoring), application (diagnostic and therapeutic), distribution channel (pharmacy/clinics, online, and others), and region (North America, Europe, APAC, and the Rest of the World)?
Q. 2. Which segments will grow at a faster pace and why?
Q. 3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and reasons behind them?
Q.7. What are some changing customer demands in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What are the strategic initiatives of key players for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material / product substitution?
Q.11. What M&A activity has occurred in the last 5 years?